These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 14044623

  • 21. Human calcitonin treatment of Paget's disease of bone.
    Singer FR.
    Clin Orthop Relat Res; 1977; (127):86-93. PubMed ID: 912995
    [Abstract] [Full Text] [Related]

  • 22. [Letter: Results of treatment of Paget's disease of bone with swine thyrocalcitonin].
    Bouvier M, Lejeune E, Daumont R, Deplante JP.
    Nouv Presse Med; 1975 Dec 13; 4(43):3070-1. PubMed ID: 1223792
    [No Abstract] [Full Text] [Related]

  • 23. Experiences in the treatment of Paget's disease of bone with mithramycin.
    Ryan WG, Schwartz TB, Northrop G.
    JAMA; 1970 Aug 17; 213(7):1153-7. PubMed ID: 5468261
    [No Abstract] [Full Text] [Related]

  • 24. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F, Baker RK, Wallach S.
    J Clin Invest; 1971 Sep 17; 50(9):1927-40. PubMed ID: 4935444
    [Abstract] [Full Text] [Related]

  • 25. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM, Iqbal SJ, Holland S, Wong M, Manning D.
    Ann Clin Biochem; 1994 Jul 17; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [Abstract] [Full Text] [Related]

  • 26. [Relations between urine excretion of hydroxyproline and alkaline serum phophatase in Paget's disease as expression of changes in collagen metabolism].
    Mühlbach R.
    Beitr Orthop Traumatol; 1966 Apr 17; 13(4):189-96. PubMed ID: 5927636
    [No Abstract] [Full Text] [Related]

  • 27. [Short term treatment of Paget's disease with porcine calcitonin].
    Renier JC, Boasson M, Jallet P, Bernat M.
    Rev Rhum Mal Osteoartic; 1973 Oct 17; 40(10):557-63. PubMed ID: 4797550
    [No Abstract] [Full Text] [Related]

  • 28. [METABOLISM OF MAGNESIUM AND ITS RELATION TO THAT OF CALCIUM. I. APROPOS OF A STUDY OF MAGNESIUM BALANCE IN THE NORMAL MAN, IN OSTEOPATHIES AND NEPHROPATHIES].
    PARLIER R, HIOCO D, LEBLANC R.
    Rev Fr Endocrinol Clin; 1963 Oct 17; 4():93-135. PubMed ID: 14054670
    [No Abstract] [Full Text] [Related]

  • 29. Salmon and porcine calcitonin treatment of Paget's disease of bone.
    Avramides A.
    Clin Orthop Relat Res; 1977 Oct 17; (127):78-85. PubMed ID: 303164
    [No Abstract] [Full Text] [Related]

  • 30. URINARY HYDROXYPROLINE EXCRETION IN MALABSORPTION STATES.
    CRABBE P, ISSELBACHER KJ.
    Gastroenterology; 1965 Mar 17; 48():307-11. PubMed ID: 14292141
    [No Abstract] [Full Text] [Related]

  • 31. Treatment of Paget's disease with mithramycin: further experiences.
    Ryan WG, Schwartz TB, Northrop G.
    Semin Drug Treat; 1972 Mar 17; 2(1):57-64. PubMed ID: 4261785
    [No Abstract] [Full Text] [Related]

  • 32. [Paget's disease of the bones: diagnosis and treatment].
    Jacobs JW, Huisman AM, van Paassen HC, Bijlsma JW.
    Ned Tijdschr Geneeskd; 1999 Apr 03; 143(14):719-25. PubMed ID: 10347626
    [Abstract] [Full Text] [Related]

  • 33. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
    Altman RD, Johnston CC, Khairi MR, Wellman H, Serafini AN, Sankey RR.
    N Engl J Med; 1973 Dec 27; 289(26):1379-84. PubMed ID: 4201876
    [No Abstract] [Full Text] [Related]

  • 34. [How to determine Paget's disease activity and which patients to treat?].
    Renier JC.
    Presse Med; 1984 May 12; 13(20):1276-7. PubMed ID: 6232591
    [No Abstract] [Full Text] [Related]

  • 35. Long term effects of dichloromethylene diphosphonate in Paget's disease of bone.
    Delmas PD, Chapuy MC, Vignon E, Charhon S, Briancon D, Alexandre C, Edouard C, Meunier PJ.
    J Clin Endocrinol Metab; 1982 Apr 12; 54(4):837-44. PubMed ID: 6460781
    [Abstract] [Full Text] [Related]

  • 36. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
    Haddad JG, Birge SJ, Avioli LV.
    N Engl J Med; 1970 Sep 10; 283(11):549-55. PubMed ID: 5450609
    [No Abstract] [Full Text] [Related]

  • 37. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
    Oreopoulos DG, Husdan H, Harrison J, Meema HE, McNeill KG, Murray TM, Ogilvie R, Rapoport A.
    Can Med Assoc J; 1977 Apr 23; 116(8):851-5. PubMed ID: 856428
    [Abstract] [Full Text] [Related]

  • 38. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC, Meunier P, Terrier M, David L, Vignon G.
    Pathol Biol (Paris); 1975 May 23; 23(5):349-59. PubMed ID: 172838
    [Abstract] [Full Text] [Related]

  • 39. Healing of the bones in juvenile Paget's disease treated by human calcitonin.
    Doyle FH, Woodhouse NJ, Glen AC, Joplin GF, MacIntyre I.
    Br J Radiol; 1974 Jan 23; 47(553):9-15. PubMed ID: 4809438
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of Paget's disease with a diphosphonate (sodium etidronate).
    Smith R, Russell RG.
    Semin Drug Treat; 1972 Jan 23; 2(1):77-81. PubMed ID: 4558759
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.